Using HSV-TK/GCV Suicide Gene Therapy to Inhibit Lens Epithelial Cell Proliferation for Treatment of Posterior Capsular Opacification

Overview

Journal Mol Vis

Specialties Cell Biology
Molecular Biology
Ophthalmology

Date 2011 Feb 2

PMID 21283526

Citations 9

Authors

Yong-Xiang Jiang

Yi Lu

Tian-Jing Liu

Jin Yang

Yan Chen

Yan-Wen Fang

Affiliations

Soon will be listed here.

Abstract

Purpose: To establish a novel, targeted lentivirus-based HSV-tk (herpes simplex virus thymidine kinase)/GCV (ganciclovir) gene therapy system to inhibit lens epithelial cell proliferation for treatment of posterior capsular opacification (PCO) after cataract surgery.

Methods: An enhanced Cre recombinase (Cre/loxP) system with a lentiviral vector expressing Cre under the control of the lens-specific promoter LEP503 (Lenti-LEP503-HSVtk-Cre [LTKCRE]) was constructed, as well as another lentiviral vector containing a switching unit. The latter vector contains a stuffer sequence encoding EGFP (Lenti-hPGK-Loxp-EGFP-pA-Loxp-HSVtk [PGFPTK]) with a functional polyadenylation signal between two loxP sites, followed by the herpes simplex virus thymidine kinase (HSV-tk) gene, both under the control of the human phosphoglycerate kinase (hPGK) promoter. Expression of the downstream gene (HSV-tk) is activated by co-expression of Cre. Human lens epithelial cells (HLECs) or retinal pigmental epithelial cells (RPECs) were co-infected with LTKCRE and PGFPTK. The inhibitory effects on HLECs and RPECs infected by the enhanced specific lentiviral vector combination at the concentration of 20 µg/ml GCV were assayed and compared.

Results: The specific gene expression of Cre and HSV-tk in HLECs is activated by the LEP503 promoter. LTKCRE and PGFPTK co-infected HLECs, but not RPECs, expressed high levels of the HSV-tk protein. After 96 h of GCV treatment, the percentage of apoptotic HLECs infected by the enhanced specific lentiviral vector combination was 87.23%, whereas that of apoptotic RPECs was only 10.12%. Electron microscopy showed that GCV induced apoptosis and necrosis of the infected HLECs.

Conclusions: The enhanced specific lentiviral vector combination selectively and effectively expressed HSV-tk in HLECs. A concentration of 20 µg/ml, GCV is effective against the proliferation of HLECs in vitro. This cell-type-specific gene therapy using a Cre/loxP lentivirus system may be a feasible treatment strategy to prevent PCO.

Citing Articles

Oxidative Stress and Cataract Formation: Evaluating the Efficacy of Antioxidant Therapies.

Kulbay M, Wu K, Nirwal G, Belanger P, Tran S Biomolecules. 2024; 14(9).

PMID: 39334822 PMC: 11430732. DOI: 10.3390/biom14091055.

Loss-of-function manipulations to identify roles of diverse glia and stromal cells during CNS scar formation.

Wahane S, Sofroniew M Cell Tissue Res. 2021; 387(3):337-350.

PMID: 34164732 PMC: 8975763. DOI: 10.1007/s00441-021-03487-8.

Sanguinarine induces apoptosis of human lens epithelial cells by increasing reactive oxygen species via the MAPK signaling pathway.

Zhang Y, Huang W Mol Med Rep. 2019; 19(5):4449-4456.

PMID: 30942394 PMC: 6472141. DOI: 10.3892/mmr.2019.10087.

Microglia Activate Migration of Glioma Cells through a Pyk2 Intracellular Pathway.

Rolon-Reyes K, Kucheryavykh Y, Cubano L, Inyushin M, Skatchkov S, Eaton M PLoS One. 2015; 10(6):e0131059.

PMID: 26098895 PMC: 4476590. DOI: 10.1371/journal.pone.0131059.

Noninvasive theranostic imaging of HSV1-sr39TK-NTR/GCV-CB1954 dual-prodrug therapy in metastatic lung lesions of MDA-MB-231 triple negative breast cancer in mice.

Sekar T, Foygel K, Ilovich O, Paulmurugan R Theranostics. 2014; 4(5):460-74.

PMID: 24669276 PMC: 3964441. DOI: 10.7150/thno.8077.

References

Wang B, Weng J . [Effects of adenovirus-mediated HSV-tk/GCV system on lens epithelium]. Zhonghua Yan Ke Za Zhi. 2002; 38(10):618-22. View

Couderc B, de Neuville S, Douin-Echinard V, Serres B, Manenti S, Darbon J . Retrovirus-mediated transfer of a suicide gene into lens epithelial cells in vitro and in an experimental model of posterior capsule opacification. Curr Eye Res. 1999; 19(6):472-82. DOI: 10.1076/ceyr.19.6.472.5284. View

Nishi O . Posterior capsule opacification. Part 1: Experimental investigations. J Cataract Refract Surg. 1999; 25(1):106-17. DOI: 10.1016/s0886-3350(99)80020-0. View

Ueda K, Iwahashi M, Nakamori M, Nakamura M, Yamaue H, Tanimura H . Enhanced selective gene expression by adenovirus vector using Cre/loxP regulation system for human carcinoembryonic antigen-producing carcinoma. Oncology. 2000; 59(3):255-65. DOI: 10.1159/000012169. View

Gu F, Zhai H, Li D, Zhao L, Li C, Huang S . A novel mutation in major intrinsic protein of the lens gene (MIP) underlies autosomal dominant cataract in a Chinese family. Mol Vis. 2007; 13:1651-6. View

Ashwin P, Shah S, Wolffsohn J . Advances in cataract surgery. Clin Exp Optom. 2009; 92(4):333-42. DOI: 10.1111/j.1444-0938.2009.00393.x. View

Yang J, Liu T, Lu Y . Effects of bicistronic lentiviral vector-mediated herpes simplex virus thymidine kinase/ganciclovir system on human lens epithelial cells. Curr Eye Res. 2007; 32(1):33-42. DOI: 10.1080/02713680601112793. View

Yadav U, Ighani-Hosseinabad F, van Kuijk F, Srivastava S, Ramana K . Prevention of posterior capsular opacification through aldose reductase inhibition. Invest Ophthalmol Vis Sci. 2008; 50(2):752-9. PMC: 2832582. DOI: 10.1167/iovs.08-2322. View

Nicholas T, Read S, Burrows F, Kruse C . Suicide gene therapy with Herpes simplex virus thymidine kinase and ganciclovir is enhanced with connexins to improve gap junctions and bystander effects. Histol Histopathol. 2003; 18(2):495-507. DOI: 10.14670/HH-18.495. View

10.

Nagayama Y, Nishihara E, Iitaka M, Namba H, Yamashita S, Niwa M . Enhanced efficacy of transcriptionally targeted suicide gene/prodrug therapy for thyroid carcinoma with the Cre-loxP system. Cancer Res. 1999; 59(13):3049-52. View

11.

Awasthi N, Guo S, Wagner B . Posterior capsular opacification: a problem reduced but not yet eradicated. Arch Ophthalmol. 2009; 127(4):555-62. DOI: 10.1001/archophthalmol.2009.3. View

12.

Denny W . Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy). J Biomed Biotechnol. 2003; 2003(1):48-70. PMC: 179761. DOI: 10.1155/S1110724303209098. View

13.

Morgenbesser S, Williams B, Jacks T, DePinho R . p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature. 1994; 371(6492):72-4. DOI: 10.1038/371072a0. View

14.

Krag S, Andreassen T . Mechanical properties of the human posterior lens capsule. Invest Ophthalmol Vis Sci. 2003; 44(2):691-6. DOI: 10.1167/iovs.02-0096. View

15.

Vasavada A, Nihalani B . Pediatric cataract surgery. Curr Opin Ophthalmol. 2006; 17(1):54-61. DOI: 10.1097/01.icu.0000193069.32369.e1. View

16.

Buyru Ozkurt Y, Sengor T, Evciman T, Haboglu M . Refraction, intraocular pressure and anterior chamber depth changes after Nd:YAG laser treatment for posterior capsular opacification in pseudophakic eyes. Clin Exp Optom. 2009; 92(5):412-5. DOI: 10.1111/j.1444-0938.2009.00401.x. View

17.

Kanegae Y, Lee G, Sato Y, Tanaka M, Nakai M, Sakaki T . Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res. 1995; 23(19):3816-21. PMC: 307296. DOI: 10.1093/nar/23.19.3816. View

18.

Maeda M, Namikawa K, Kobayashi I, Ohba N, Takahara Y, Kadono C . Targeted gene therapy toward astrocytoma using a Cre/loxP-based adenovirus system. Brain Res. 2006; 1081(1):34-43. DOI: 10.1016/j.brainres.2006.01.105. View

19.

Greco O, Joiner M, Doleh A, Powell A, Hillman G, Scott S . Hypoxia- and radiation-activated Cre/loxP 'molecular switch' vectors for gene therapy of cancer. Gene Ther. 2005; 13(3):206-15. DOI: 10.1038/sj.gt.3302640. View

20.

Kijima T, Osaki T, Nishino K, Kumagai T, Funakoshi T, Goto H . Application of the Cre recombinase/loxP system further enhances antitumor effects in cell type-specific gene therapy against carcinoembryonic antigen-producing cancer. Cancer Res. 1999; 59(19):4906-11. View